| RS1603215383 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS1603216806 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS1603216830 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS1603217176 |
SLC6A8
|
Health Risk |
Pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS1603217468 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS1603217473 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS1603218449 |
MT-TF
|
Health Risk |
Conflicting classifications of pathogenicity |
MELAS syndrome, MELAS syndrome |
| RS1603218856 |
MT-TL1
|
Health Risk |
Likely pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS1603218878 |
MT-TL1
|
Health Risk |
Likely pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS1603219020 |
MT-ND1
|
Health Risk |
Likely pathogenic |
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency, Mitochondrial disease |
| RS1603219126 |
MT-ND1
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, See cases |
| RS1603219805 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS1603220010 |
MT-TW
|
Health Risk |
Likely pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS1603220762 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Inborn genetic diseases |
| RS1603221634 |
MT-ATP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Leigh syndrome |
| RS1603221854 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603222000 |
MT-ATP6
|
Health Risk |
Likely pathogenic |
Progressive cerebellar ataxia, Leigh syndrome |
| RS1603222095 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603222314 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Intellectual disability-hypotonic facies syndrome |
| RS1603222424 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603222556 |
DMD
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 3B, Duchenne muscular dystrophy |
| RS1603222574 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603222897 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603222922 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603223001 |
BCAP31
|
Health Risk |
Pathogenic |
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome, Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome |
| RS1603223025 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603223152 |
AIFM1
|
Health Risk |
Pathogenic |
Severe X-linked mitochondrial encephalomyopathy, Severe X-linked mitochondrial encephalomyopathy |
| RS1603223158 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Combined oxidative phosphorylation deficiency |
| RS1603223645 |
MT-TL2
|
Health Risk |
Likely pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS1603223646 |
MT-TL2
|
Health Risk |
Conflicting classifications of pathogenicity |
MELAS syndrome, Mitochondrial disease |
| RS1603223730 |
MT-ND5
|
Health Risk |
Likely pathogenic |
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency, MELAS syndrome |
| RS1603223971 |
MT-ND5
|
Health Risk |
Likely pathogenic |
Leigh syndrome, MELAS syndrome |
| RS1603224015 |
MT-ND5
|
Health Risk |
Likely pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS1603224029 |
MT-ND5
|
Health Risk |
Pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS1603224043 |
MT-ND5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Leigh syndrome |
| RS1603224226 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe X-linked mitochondrial encephalomyopathy, Charcot-Marie-Tooth disease X-linked recessive 4 |
| RS1603224738 |
MT-ND6
|
Health Risk |
Likely pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS1603224770 |
MT-ND6
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS1603224817 |
AIFM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked recessive 4, Charcot-Marie-Tooth disease X-linked recessive 4 |
| RS1603224966 |
MT-CYB
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Leigh syndrome |
| RS1603225138 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe X-linked mitochondrial encephalomyopathy, Charcot-Marie-Tooth disease X-linked recessive 4 |
| RS1603225182 |
AIFM1
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Bieganski type |
| RS1603226023 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603226766 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Inborn genetic diseases |
| RS1603227409 |
AIFM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked recessive 4, Charcot-Marie-Tooth disease X-linked recessive 4 |
| RS1603231653 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603231784 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603231848 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603231897 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603231911 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603232111 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603232195 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603232237 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603232243 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603233089 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603233113 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603233120 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603234451 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603234466 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603234501 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603234574 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603234759 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603234766 |
ABCD1;PLXNB3-AS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235263 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235267 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235321 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235389 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235394 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235406 |
ABCD1
|
Health Risk |
Pathogenic |
— |
| RS1603235421 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235901 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603235941 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603236012 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603236013 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603236020 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603236086 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1603236385 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1603236465 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS1603238847 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, Thyroid cancer |
| RS1603240572 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Intellectual disability-hypotonic facies syndrome |
| RS1603240717 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS1603241575 |
TBX2
|
Health Risk |
Likely pathogenic |
TBX2-related disorder, TBX2-related disorder |
| RS1603241972 |
PLS3
|
Health Risk |
Likely pathogenic |
Bone mineral density quantitative trait locus 18, Bone mineral density quantitative trait locus 18 |
| RS1603244482 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1603244690 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1603246794 |
THOC2
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-short stature-overweight syndrome, X-linked intellectual disability-short stature-overweight syndrome |
| RS1603248167 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary hypertension |
| RS1603248606 |
TBX4
|
Health Risk |
Pathogenic |
Coxopodopatellar syndrome, Pulmonary hypertension |
| RS1603251001 |
TBX4
|
Health Risk |
Pathogenic |
Autosomal recessive amelia, Coxopodopatellar syndrome |
| RS1603251494 |
TBX4
|
Health Risk |
Pathogenic |
6 conditions, Autosomal recessive amelia |
| RS1603253563 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603253605 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1603254792 |
TBX4
|
Health Risk |
Pathogenic |
— |
| RS1603255224 |
TBX4
|
Health Risk |
Likely pathogenic |
Coxopodopatellar syndrome, Pulmonary hypertension |
| RS1603255267 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS1603255327 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary hypertension |
| RS1603255336 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS1603255339 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS1603255389 |
THOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked intellectual disability-short stature-overweight syndrome, X-linked intellectual disability-short stature-overweight syndrome |
| RS1603256040 |
TBX4
|
Health Risk |
Pathogenic/Likely pathogenic |
Coxopodopatellar syndrome, Pulmonary hypertension |